Patients who undergo BPC-157 therapy often experience shorter recovery times, reduced discomfort, and enhanced resilience against long-term damage
In tendon and ligament research, BPC-157 stimulates collagen synthesis through tendon-derived fibroblast activity and counteracts the anti-healing effects that NSAIDs and corticosteroids can impose on connective tissue, which is clinically relevant for patients who have used these medications prior to starting a peptide protocol
This forceful impact can damage the peptide structures
however, it is sold strictly for research use only
After conventional treatment, whichever option is used, patients almost always have less bothersome symptoms
Lee HS, Amarakoon D, Wei CI, Choi KY, Smolensky D, Lee SH